Faisal Khurshid
Stock Analyst at Jefferies
(4.97)
# 75
Out of 4,966 analysts
254
Total ratings
64.5%
Success rate
72.6%
Average return
Main Sectors:
Stocks Rated by Faisal Khurshid
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Upgraded: Buy | $15 → $25 | $17.55 | +42.45% | 5 | Sep 9, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Hold | $230 → $260 | $248.68 | +4.55% | 4 | Sep 8, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $270 | $203.77 | +32.50% | 4 | Sep 3, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $290 → $330 | $263.52 | +25.23% | 3 | Aug 31, 2026 | |
| IMTX Immatics | Rated: Buy | $18 → $17 | $8.62 | +97.22% | 2 | Aug 25, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $30 → $8 | $4.28 | +86.92% | 2 | Aug 17, 2026 | |
| INSM Insmed | Reiterated: Buy | $160 → $175 | $129.41 | +35.23% | 6 | Aug 6, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $25 | $14.07 | +77.68% | 1 | Jul 31, 2026 | |
| ONC BeOne Medicines AG | Upgraded: Buy | $333 → $380 | $346.51 | +9.66% | 3 | Jul 12, 2026 | |
| ABVX ABIVAX Société Anonyme | Upgraded: Buy | $90 → $158 | $118.64 | +33.18% | 4 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $30 | $21.24 | +41.24% | 2 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $8 | $7.32 | +9.29% | 2 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $76 → $85 | $66.06 | +28.67% | 2 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $37 | $18.18 | +103.52% | 2 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $13.17 | +59.45% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $120 | $71.18 | +68.59% | 14 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $33.41 | +64.62% | 1 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $14.63 | +2.53% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 | $33.14 | -0.42% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $94 | $121.47 | -22.61% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $118 → $110 | $116.47 | -5.56% | 16 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $14.86 | +41.37% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $142 | $104.00 | +36.54% | 8 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $4 | $10.89 | -63.27% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $25.61 | -53.13% | 8 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $29 → $40 | $26.84 | +49.03% | 11 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 → $9 | $3.75 | +140.00% | 11 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.4298 | - | 17 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.82 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.21 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.14 | - | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.42 | - | 13 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $148.18 | - | 2 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $88.28 | n/a | 10 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $2 | $6.20 | n/a | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.35 | n/a | 17 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $4.08 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.17 | n/a | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $73.26 | n/a | 1 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.739 | n/a | 7 | Nov 9, 2023 |
Summit Therapeutics
Sep 9, 2026
Upgraded: Buy
Price Target: $15 → $25
Current: $17.55
Upside: +42.45%
Alnylam Pharmaceuticals
Sep 8, 2026
Reiterated: Hold
Price Target: $230 → $260
Current: $248.68
Upside: +4.55%
Revolution Medicines
Sep 3, 2026
Reiterated: Buy
Price Target: $270
Current: $203.77
Upside: +32.50%
Ascendis Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $290 → $330
Current: $263.52
Upside: +25.23%
Immatics
Aug 25, 2026
Rated: Buy
Price Target: $18 → $17
Current: $8.62
Upside: +97.22%
EyePoint
Aug 17, 2026
Reiterated: Buy
Price Target: $30 → $8
Current: $4.28
Upside: +86.92%
Insmed
Aug 6, 2026
Reiterated: Buy
Price Target: $160 → $175
Current: $129.41
Upside: +35.23%
Monte Rosa Therapeutics
Jul 31, 2026
Reiterated: Buy
Price Target: $25
Current: $14.07
Upside: +77.68%
BeOne Medicines AG
Jul 12, 2026
Upgraded: Buy
Price Target: $333 → $380
Current: $346.51
Upside: +9.66%
ABIVAX Société Anonyme
Jul 1, 2026
Upgraded: Buy
Price Target: $90 → $158
Current: $118.64
Upside: +33.18%
Jun 30, 2026
Reiterated: Buy
Price Target: $29 → $30
Current: $21.24
Upside: +41.24%
Jun 23, 2026
Reiterated: Buy
Price Target: $15 → $8
Current: $7.32
Upside: +9.29%
May 27, 2026
Upgraded: Buy
Price Target: $76 → $85
Current: $66.06
Upside: +28.67%
May 1, 2026
Reiterated: Buy
Price Target: $40 → $37
Current: $18.18
Upside: +103.52%
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $13.17
Upside: +59.45%
Mar 25, 2026
Reiterated: Buy
Price Target: $103 → $120
Current: $71.18
Upside: +68.59%
Mar 16, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $33.41
Upside: +64.62%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $14.63
Upside: +2.53%
Mar 15, 2026
Downgraded: Hold
Price Target: $33
Current: $33.14
Upside: -0.42%
Mar 15, 2026
Downgraded: Hold
Price Target: $94
Current: $121.47
Upside: -22.61%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $118 → $110
Current: $116.47
Upside: -5.56%
Dec 15, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $14.86
Upside: +41.37%
Dec 15, 2025
Reiterated: Buy
Price Target: $142
Current: $104.00
Upside: +36.54%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $4
Current: $10.89
Upside: -63.27%
Oct 23, 2025
Reiterated: Hold
Price Target: $12
Current: $25.61
Upside: -53.13%
Oct 22, 2025
Upgraded: Buy
Price Target: $29 → $40
Current: $26.84
Upside: +49.03%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $7 → $9
Current: $3.75
Upside: +140.00%
Sep 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.4298
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.82
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $5.21
Upside: -
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.14
Upside: -
Sep 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $11.42
Upside: -
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $148.18
Upside: -
Sep 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $88.28
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $4 → $2
Current: $6.20
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $3
Current: $1.35
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $4.08
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $2
Current: $1.17
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $73.26
Upside: n/a
Nov 9, 2023
Reiterated: Hold
Price Target: $2
Current: $0.739
Upside: n/a